Berman Capital Advisors’s Qiagen QGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
$23K Buy
431
+125
+41% +$6.96K ﹤0.01% 935
2021
Q2
$15K Sell
306
-80
-21% -$4.13K ﹤0.01% 1008
2021
Q1
$19K Buy
386
+155
+67% +$8.52K ﹤0.01% 810
2020
Q4
$12K Buy
231
+117
+103% +$6.24K ﹤0.01% 854
2020
Q3
$6K Hold
114
﹤0.01% 982
2020
Q2
$5K Buy
114
+59
+107% +$2.64K ﹤0.01% 989
2020
Q1
$1K Buy
55
+32
+139% +$1.25K ﹤0.01% 1350
2019
Q4
$0 Sell
23
-158
-87% -$5.87K ﹤0.01% 1527
2019
Q3
$6K Sell
181
-123
-40% -$4.73K ﹤0.01% 904
2019
Q2
$13K Buy
304
+67
+28% +$2.78K ﹤0.01% 648
2019
Q1
$10K Buy
237
+56
+31% +$2.25K ﹤0.01% 666
2018
Q4
$5K Buy
+181
New +$6.72K ﹤0.01% 698

Other funds holding QGEN

Berman Capital Advisors's QGEN Position: Q3 2021 in Review

Berman Capital Advisors increased its Qiagen (QGEN) stake by 41% in Q3 2021, buying an estimated $6.96K and bringing the position to 431 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #935.

Berman Capital Advisors first reported a position in QGEN in Q4 2018 and has held it in 12 quarters since. 265 funds tracked by Wall St. Rank hold QGEN as of Q3 2021.

  • Berman Capital Advisors held 431 shares of Qiagen worth $23K as of Q3 2021.
  • Berman Capital Advisors bought 125 Qiagen shares in Q3 2021, an estimated $6.96K.
  • Qiagen made up ﹤0.01% of Berman Capital Advisors's portfolio in Q3 2021, its #935 holding.
  • Berman Capital Advisors first reported a position in Qiagen in Q4 2018 and has held it in 12 quarters since.
  • 265 funds tracked by Wall St. Rank held Qiagen as of Q3 2021.

Based on Berman Capital Advisors's 13F filing for Q3 2021, filed 7 Oct 2021.